The U.S. Food and Drug Administration failed to address safety concerns when it expanded access to the abortion drug mifepristone in 2016 and 2021, according to the 5th U.S. Circuit Court of Appeals at New Orleans.
It’s been more than a year since the U.S. Supreme Court overturned Roe v. Wade in Dobbs v. Jackson Women’s Health Organization, but members of the House of Delegates continued to discuss wide-ranging issues that stem from the landmark decision at the ABA Annual Meeting on Monday.
This year’s recipients of the Silver Gavel Awards for Media and the Arts delve into a multitude of pressing and prominent legal issues, including abortion rights, affirmative action and modern-day slavery.
Newly released private papers of then-Justice John Paul Stevens provide insight into U.S. Supreme Court deliberations and concerns before its decisions that decided a presidential election and affirmed the right to abortion.
Justice Samuel Alito says he personally has “a pretty good idea who is responsible” for the May 2, 2022, leak of the U.S. Supreme Court’s abortion decision, “but that’s different from the level of proof that is needed to name somebody.”
A Texas federal judge who blocked access to the abortion drug mifepristone did not disclose certain information about the millions of dollars in stock that he owns when he filled out financial disclosure forms for 2020 and 2021.
Justices Samuel Alito and Clarence Thomas dissented from the U.S. Supreme Court’s decision Friday to allow continued full access, for now, to the abortion medication mifepristone. But Alito spoke only for himself in a written dissent; Thomas did not indicate the reason for his dissent.